Search This Blog

Saturday, June 25, 2022

New Jersey City ‘Weaponizes’ Parking Rules to Cut Traffic Fatalities

 As cities and states across the country are seeing jumps in traffic accidents and pedestrian fatalities, a series of aggressive public safety initiatives have helped the city of Hoboken, NJ cut down crashes, injuries and deaths, Curbed reports.

For Curbed, reporter Christopher Robbins interviewed Ryan Sharp, Hoboken’s Director of Transportation and Parking. Sharp said Hoboken’s DOT has “weaponized” an already-existing law: New Jersey traffic regulations prohibit parking within 25 feet of a crosswalk, about one parking spot’s worth of space.

“Because it’s dead space, right? So what can we do with that space?” Sharpe said. “Get more utility in an urban environment, where every square inch, every square foot, of space is so valuable.”

Hoboken fills that buffer zone up, blocking it off from drivers with bike racks, extended sidewalks, and other utilitarian obstacles.

Clearing that space is part of a safety strategy called daylighting,” expanding sight-lines and overall visibility between pedestrians and motorists at an intersection

Sharp credits a great deal of Hoboken’s success to the city’s investment in public space and commitment to addressing traffic dangers from Mayor Ravi Bhalla down to the city council.

diagvram

Graphic showing how daylighting streets increases visibility Credit: NACTO Urban Street Design Guide

Other cities can make these changes too. The National Association of City Transportation Officials recommends in its Urban Street Design Guide that cities across the country start implementing a 20-25 feet parking exclusion area around intersections to daylight them and make them safer.

Hoboken’s public safety success comes while the United States weathers a shocking increase in pedestrian deaths across the country.

In 2021, New Jersey State Police reported the state’s highest number of pedestrian fatalities in over 30 years and greatest number of traffic deaths of any kind since 2007. Fatal accidents in New Jersey have increased 18.6 percent in 2022 compared to the same period in 2021, too.

Hoboken hasn’t had a single traffic fatality since 2018.

https://thecrimereport.org/2022/06/20/new-jersey-city-weaponizes-parking-rules-to-cut-traffic-fatalities/

Abortion ruling raises stakes in key U.S. governor's races

 

Abortion is now front and center in November's key governor's races in Pennsylvania and Michigan, after the U.S. Supreme Court overturned the landmark Roe v. Wade decision that had recognized a constitutional right to abortion.

Kansas residents, meanwhile, will vote on whether to protect abortion rights in an August ballot measure, now that Roe has been reversed. And abortion will play a consequential role in other gubernatorial and state legislative races around the country, with Democrats aiming to leverage anger over the issue ahead of the Nov. 8 midterm elections.

The Supreme Court ruling overturning Roe handed the power of legalizing or banning abortion to the states, setting the stage for a patchwork of policies across the nation, with many Republican-controlled states expected to outlaw it. Democrats hold too small a majority in Congress to pass national legislation, leaving state legislatures and governors the critical actors.

Senior Democrats hope the decision will motivate their supporters in November and win over swing voters, but economic issues and high inflation are also expected to remain top concerns among voters.

"The 2022 elections are going to send a crystal clear message to elected officials across the country," said Wisconsin's Democratic attorney general, Josh Kaul, on a conference call with journalists on Saturday. "We have it within our power to send a very powerful message, a message that we will not accept politicians taking rights away from Americans."

In Pennsylvania, Republican gubernatorial nominee Doug Mastriano, a state senator, previously sponsored a "heartbeat" bill that would ban abortions after around six weeks, before most women know they are pregnant. He has expressed support for a total ban without exceptions, including for the life of the mother, and referred to abortion as "genocide."

With Republicans in control of the state legislature, a Mastriano victory this fall would likely prompt lawmakers to pass new abortion restrictions.

The Democratic candidate, Attorney General Josh Shapiro, has vowed to protect abortion rights if elected.

"Our Republican legislature will send a bill to our next governor's desk to ban abortion in Pennsylvania," he said on Twitter after Friday's ruling. "Without Roe, the only thing stopping them is the veto pen of our next governor."

1931 LAW

In Michigan, Democratic Governor Gretchen Whitmer and Planned Parenthood both have filed lawsuits seeking to block a 1931 law that bans abortions from retaking effect in the event that the Supreme Court overturned Roe.

A state court judge in May temporarily put the 91-year-old law on hold while the litigation proceeds.

Whitmer is running for reelection this fall. The top Republican candidates, who will face off in an Aug. 2 primary, all oppose abortion rights, and the state legislature's two chambers are both controlled by Republicans.

"I will fight like hell to protect every Michigander's right to make decisions about their own body with the advice of a medical professional they trust," Whitmer said in a statement on Friday.

Michigan abortion rights advocates are seeking to put a ballot measure before voters in November that would enshrine a right to abortion in the state constitution.

In Kansas, the state Supreme Court ruled in 2019 that abortion is protected under the state constitution. But voters on Aug. 2 will decide whether to approve an amendment stripping abortion rights from the constitution, opening the door for the Republican-controlled legislature to pass new limits.

Democratic Kansas Governor Laura Kelly, who supports abortion rights, is running for re-election. Republicans currently hold a legislative super-majority, enough to override any gubernatorial veto.

In some other battleground states, Democratic gubernatorial candidates who support abortion rights have few options in the face of pre-existing laws and Republican-controlled legislatures.

In Wisconsin, Friday's decision reinstated an 1849 state law banning all abortions except to save the life of the mother, though litigation challenging the statute is expected.

Governor Tony Evers, a Democrat, called lawmakers into a special session this month to repeal the law, but Republicans adjourned the session without taking action. Evers is also running for reelection in November.

In Georgia, a "heartbeat" bill appears likely to take effect following the Supreme Court decision. Democrat Stacey Abrams, who is challenging Republican Governor Brian Kemp in November, supports abortion rights but would have little recourse with a Republican-dominated legislature.

Some Republican lawmakers in Georgia have advocated for a full abortion ban; Kemp, who praised Friday's ruling, has not said whether he would support such a step.

https://www.marketscreener.com/news/latest/Abortion-ruling-raises-stakes-in-key-U-S-governor-s-races--40813178/

As US obesity epidemic grows, new study shows who is gaining weight ove lastr decade

 Newly published research from BYU exercise science researchers reveals critical, rare data detailing the severity of the obesity epidemic in the United States.

The article, published in the Journal of Obesity, looked at the long-term weight gain of more than 13,800 U.S. adults -- a rare data point unearthed in obesity research. They found that more than half of American adults in the study gained 5% or more body weight over a 10-year period. What's more, more than a third of American adults gained 10% or more body weight and almost a fifth gained 20% or more body weight.

"The U.S. obesity epidemic is not slowing down," said study lead author Larry Tucker, a BYU professor of exercise science. "Without question, 10-year weight gain is a serious problem within the U.S. adult population."

Study participants were selected randomly as part of the National Health and Nutrition Examination Survey, an annual survey that examines a nationally representative sample. NHANES is a CDC-sponsored series of studies that began in the early 1960s and became a continuous program in 1999.

Using the NHANES data, the study also found that 10-year weight gain was significantly greater in women than in men, with women gaining about twice as much weight: 12 pounds on average for women compared to 6 pounds for men. Weight gain also differed across races, with Black women experiencing the greatest average weight gain over the 10-year period (19.4 pounds) and Asian men experiencing the least (2.9 pounds).

As far as age goes, the greatest gains in weight were found in young and middle-aged adults; less weight is gained as age increases. According to the data, on average Americans gain the following weight:

  • 17.6 pounds between their 20s and 30s
  • 14.3 pounds between their 30s and 40s
  • 9.5 pounds between their 40s and 50s
  • 4.6 pounds between their 50s and 60s

If adults gain the average amount of weight during each decade of adult life, they will have gained more than 45 pounds, which would push many of them into the obese category. According to the Department of Health and Human Services and the CDC, 42.4% of U.S. adults are currently obese. That's up substantially from the 30.5% measured in 2000.

"In roughly 20 years, the prevalence of obesity increased by approximately 40% and severe obesity almost doubled," Tucker said. "By knowing who is more likely to become obese, we can help health care providers and public health officials focus more on at-risk individuals."


Story Source:

Materials provided by Brigham Young University. Original written by Todd Hollingshead. Note: Content may be edited for style and length.


Journal Reference:

  1. Larry A. Tucker, Kayla Parker. 10-Year Weight Gain in 13,802 US Adults: The Role of Age, Sex, and RaceJournal of Obesity, 2022; 2022: 1 DOI: 10.1155/2022/7652408

Oral antiviral drug effective against respiratory syncytial virus (RSV)

 An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment against RSV disease, according to researchers in the Center for Translational Antiviral Research at Georgia State University.

The findings, published in the journal Science Advances, identify AVG-388 as the lead drug candidate, which effectively blocks the activity of the viral RNA polymerase, an enzyme responsible for replication of the viral genome. RSV is a leading cause of lower respiratory infections in infants and immunocompromised individuals, but no efficient therapeutic exists. The virus caused an estimated 33.1 million cases worldwide in 2015 that required 3.2 million hospitalizations and resulted in 59,800 deaths.

Finding effective drugs to fight RSV has been challenging. Through mutations, RSV has escaped advanced candidate classes that prevent the virus from entering a cell. To overcome this issue, recent drug development efforts have focused on the viral RNA-dependent RNA polymerase complex of RSV because of the possible broader window of opportunity to fight the virus during viral genome replication and transcription.

"We have identified the AVG class of inhibitors of RSV RNA synthesis," said Dr. Richard K. Plemper, senior author of the study, Distinguished University Professor and director of the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State. "Through chemical optimization, we have developed the clinical candidate AVG-388, which is orally efficacious against RSV in animal models of infection."

In addition, the researchers demonstrated potent antiviral activity in human airway epithelium organoid cultures.

"In this study, we have mapped an exciting druggable target in the RSV RNA-dependent RNA-polymerase and established the clinical potential of the AVG inhibitor class against RSV disease," said Dr. Julien Sourimant, first author of the study and a postdoctoral fellow in the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State.

The research team investigated the effect of treatment on viral replication at different oral doses intended to prevent or cure disease. They demonstrated that treatment reduced virus load by several orders of magnitude in the different disease models.

"Our results lay the foundation for formal development of the AVG class and the structure-guided identification of companion drugs with overlapping target sites but distinct resistance profiles," Plemper said.

Co-authors of the study include Julien Sourimant (first author), Carolin M. Lieber, Jeong-Joong Yoon, Mart Toots and Richard K. Plemperof the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State; Mugunthan Govindarajan, Venkata Udumula and Michael G. Natchusof Emory Institute for Drug Development at Emory University; Kaori Sakamotoof the College of Veterinary Medicine at the University of Georgia; Joseph Pattiof Aviragen Therapeutics Inc. (now at JP Biotech Advisors Inc.); and John Vernachioof Aviragen Therapeutics Inc.

The study was funded by the National Institutes of Health.


Story Source:

Materials provided by Georgia State UniversityNote: Content may be edited for style and length.


Journal Reference:

  1. Julien Sourimant, Carolin M. Lieber, Jeong-Joong Yoon, Mart Toots, Mugunthan Govindarajan, Venkata Udumula, Kaori Sakamoto, Michael G. Natchus, Joseph Patti, John Vernachio, Richard K. Plemper. Orally efficacious lead of the AVG inhibitor series targeting a dynamic interface in the respiratory syncytial virus polymeraseScience Advances, 2022; 8 (25) DOI: 10.1126/sciadv.abo2236

'HIPAA won’t protect you if prosecutors want your reproductive health records'

 With Roe v. Wade now overturned, patients are wondering whether federal laws will shield their reproductive health data from state law enforcement, or legal action more broadly. The answer, currently, is no.

If there’s a warrant, court order, or subpoena for the release of those medical records, then a clinic is required to hand them over. And patients and providers may be made legally vulnerable by the enormous trail of health-related data we all generate through their devices every day.

As far as health records go, the most salient law is HIPAA — the Health Insurance Portability and Accountability Act. It’s possible that federal officials could try to tweak it, so records of reproductive care or abortion receive extra protection, but legal experts say that’s unlikely to stand up in the courts in a time when many judges tend to be unfriendly to executive action.

While abortion will remain legal in many states, 22 have laws on the books that will ban the procedure or lead to severely restricted access to it, according to the Guttmacher Institute.

It’s hard to know exactly how state authorities will react to this ruling. Many anti-abortion groups oppose the criminalization of abortion patients. Experts have serious concerns about how holes in privacy laws might potentially open clinicians and patients up to legal action, but the issues discussed here are possible, not certain, consequences of Friday’s decision.

HIPAA in a post-Roe world

“People think HIPAA protects a lot more health information than it actually does,” said Kayte Spector-Bagdady, a professor of bioethics and law at the University of Michigan.

It all comes down to state law. She said the federal privacy rule contains exceptions that could allow prosecutors to compel businesses to relinquish information relevant to a criminal investigation — and the same is true for other kinds of legal action, too.

“All that [a] provider could use to push back is to say, ‘I want to see a warrant,’ or ‘I want to see a subpoena,” said Carmel Shachar, executive director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.

While many laws limiting abortion have focused on providers, legal experts say some patients could end up being vulnerable, too.

In states that ban abortion, simply the suspicion that a patient had an abortion would be enough to allow law enforcement to poke around in their medical records under the guise of identifying or locating a suspect, said Isabelle Bibet-Kalinyak, a member of Brach Eichler’s health care law practice. “They would still need to have probable cause,” she said.

There are situations in which obtaining certain kinds of sensitive health information can be made more difficult for authorities to access — adding hoops to jump through, without shielding the data entirely. “You can say, OK, well, if law enforcement wants medical records relating to reproductive health, they need to work with a federal prosecutor in order to get them,’ ” said Shachar. “Maybe that would make it so difficult that state prosecutors would be reluctant to take these cases.”

She mentioned certain states’ higher standards for release of mental health records and HIV status, for instance. But those aren’t currently in place for reproductive health care, and would remain permeable.

“I think this is a wake-up call about the limitations of HIPAA,” said Adrian Gropper, chief technology officer of the Patient Privacy Rights Foundations. Though abortion is a highly partisan issue, he sees the need for better patient privacy laws as one that both Democrats and Republicans could agree on.

For now, most health law experts see very little protection of patient privacy. Look at the history of HIPAA-related cases, Gropper said, and “you would find very few examples of enforcement actions for patient privacy breaches.”

The free-flow of data in health care and the broader economy may also be used to directly discriminate against people based on their use of reproductive health services. If an employer has a certain position on abortion, you may be denied a job if “they used some predictive algorithm” to examine data available to employers on your medical care, said Andrea Downing, president and co-founder of The Light Collective, a nonprofit that advocates for stronger health data protections.

“Anything you do in health care, in our current state of (regulation), can be used against you,” she said.

Health data beyond HIPAA

In states with abortion bans, patients have more than their official medical records to think about.

“If I was giving my sister or best friend some advice, the first thing I would say is to be very careful about what data in general you’re generating,” Shachar said. “We think about medical records, but our phones collect an amazing amount of data. It’s not a good idea to send texts about your intent to seek an abortion. It’s not a good idea to use an online payment app to buy these services. You might want to leave your phone at home as opposed to taking it to the clinic. You may not even want to search for abortion providers on your phone or computer.”

Spector-Bagdady added that a large economy of health information also operates beyond the control of HIPAA, allowing the makers of period-tracking apps and other devices to share customer information with third parties in some instances.

“Some of these (businesses) have sold or shared information that is fully identified in the past with other companies such as Facebook,” she said. She noted a lawsuit the state of California recently pursued against Glow, a company that makes menstrual cycle tracking software, for sharing reproductive health information outside the app. But the violation in that case stemmed from more rigorous data protection rules in California that are not in place in other states.

In addition, neither HIPAA, nor state consumer protection rules, prohibit the disclosure of huge amounts of health information transmitted outside medical settings — in retail stores, social media sites, online shopping accounts, text messages, and elsewhere.

“The more online you are, the greater your exposure,” said Eric Perakslis, a health privacy and cybersecurity expert at Duke University. “You have your CVS account, your online patient portal, your email where appointment reminders are sent, your SMS stream on your phone. You can see how the threat compounds. It’s very difficult for people to think through that because they compartmentalize.”

The impact of the ruling will also create greater disadvantages along racial and economic lines, because people with the fewest resources cannot always afford to get services from providers that offer stronger privacy protections, Perakslis said.

“People with less means might be using the free clinic or Planned Parenthood, whereas the wealthy and well-insured are going to the nice medical office building,” he said. “The data kind of stands out more. People with less means are more exposed.”

Crossing state lines for an abortion

One question that remains is what might happen if states try to ban their residents from going elsewhere in the U.S. to seek an abortion.

Justice Brett Kavanaugh’s concurring opinion suggested that crossing state lines should not be prohibited. “He believes there is a constitutional right to interstate travel for abortion,” said I. Glenn Cohen, a professor at Harvard Law School. Cohen wasn’t sure other conservative justices would hold the same view, though.

“There’s something that feels very alarming about a state saying you may not travel outside my borders to receive medical care,” said Shachar. “We’ve traditionally always had freedom of movement between states.” That became an issue during the pandemic, as states tried to put testing mandates into place for out-of-state travelers, but “ultimately the state didn’t really have great levers to require that.”

Of course, interstate travel, if legally protected, “may be an option for some individuals, but not if you have disability, or you’re poor or you have an abusive partner who will beat you up if they find out,” said Cohen.

Murky distinction between abortions and miscarriages

Another issue is that the same medications that are used for chemical abortions are also used to treat miscarriages, to ensure that they are safely expelled from the body.

“In the medical records, it’s going to be hard to distinguish who is seeking an abortion, and who is seeking care after happening to miscarry at home,” said Shachar.

“What alarms me about the lack of privacy of medical records is, even if you’re a provider who isn’t providing abortions, but you’re providing good care for your patients, some of whom are miscarrying, those medical records could be discoverable, and could be used in criminal cases against the provider.”

While people have have already been prosecuted for miscarriages in a number of states — in cases of drug use during pregnancy, for instance — experts warn that those sorts of cases might become more common. That’s just one of the instances in which this Supreme Court decision may reveal the holes in American health privacy laws, and may result in some patients being afraid to seek medical care.

https://www.statnews.com/2022/06/24/hipaa-wont-protect-you-if-prosecutors-want-your-reproductive-health-records/

Biden admin wants to get tough on states’ abortion pill curbs. It won’t be easy

 Attorney General Merrick Garland is hinting he’s ready to get tough on states that block access to an FDA-approved pill used to terminate pregnancies.

He’s got a lot of work ahead of him.

On Friday, the Supreme Court ruled that the U.S. Constitution does not protect the right to an abortion, overruling the landmark 1973 Roe v. Wade decision. In response, the Justice Department declared that it will “work tirelessly to protect and advance reproductive freedom.” Namely, it warned that states can’t restrict access to mifepristone, a drug approved by the FDA in 2000 to terminate pregnancies.

“The FDA has approved the use of the medication mifepristone. States may not ban mifepristone based on disagreement with the FDA’s expert judgment about its safety and efficacy,” Garland wrote in a statement.

Despite Garland’s declaration, more than 30 states have already enacted some form of mifepristone restrictions, according to the Guttmacher Institute, a think tank that supports abortion rights. Some states have had those restrictions on the books for years, and even Democratic administrations have never challenged them.

Legal scholars who spoke with STAT say that states’ mifepristone restrictions are, in fact, vulnerable to a potential legal challenge. That’s because the FDA has the sole authority to approve drugs in the United States. There’s legal precedent, too, for courts striking down states’ restrictions on FDA-approved drugs. Massachusetts’ effort to ban the opioid Zohydro, for example, was struck down because the FDA’s approval of the drug “preempted” the state law.

Patti Zettler, an associate professor of law at Ohio State University, put it simply: “When state and federal law conflict, federal law wins.”

But it won’t be easy to crack down on the mifepristone restrictions — and the process will take some time and creative lawyering.

“It’s true that it is not a slam dunk,” said Greer Donley, an assistant professor of law at the University of Pittsburgh, who authored one of the first papers arguing that mifeprestone laws could be challenged to protect abortion access.

Donley guessed it could take “at least a year, if not two,” for mifepristone restrictions to be overturned — and even longer if the fight gets caught up in appeals.

The potential obstacles are myriad.

First, states have gotten crafty in their restrictions, making them more difficult to challenge.

From a legal perspective, an outright ban on mifepristone would be the easiest to challenge in court, but few states have actually pursued that sort of ban. Instead, they’ve erected restrictions like requirements that people be prescribed the drug in person, which could be especially difficult in states where abortion is banned.

Challenging those sorts of restrictions would likely be more difficult, though proponents of the legal theory insist it can be done.

Zettler, the Ohio State professor, wrote in the New England Journal of Medicine that these restrictions likely could still be challenged by arguing that the state’s restrictions upset the balance the FDA struck when it crafted its safety system, known as a REMS, for the abortion drug.

Even Zettler acknowledged, however, that the argument is not perfect.

“I don’t think that argument is necessarily a complete slam dunk, but I do think there’s a strong argument to be made,” she told STAT.

Second, there’s the question of where to bring a lawsuit. While judges are supposed to be impartial regardless of their political leanings, experts fear that judges in conservative states that most commonly have mifepristone restrictions will be less willing to strike down these rules.

“The problem here is that many of the states that ban abortion are in circuits where the judges are quite hostile to any kind of effort to expand abortion access,” said Donley. “The DOJ here would have to be really thoughtful about what jurisdiction it brought this challenge in.”

And even if a court rules that mifepristone restrictions are “preempted,” it’s unclear how the Supreme Court would rule on that question if the decision was appealed, explained I. Glenn Cohen, the deputy dean of Harvard Law School.

“What they will decide on the issue, I think, is much less certain,” said Cohen. “Preemption makes some strange bedfellows and it’s not something where … there is strong visibility into what Amy Coney Barrett’s views of preemption are.”

And third, the Department of Justice is going to have to contend with an existing lawsuit already challenging one state’s mifepristone restrictions.

One mifepristone manufacturer, GenBioPro, has already brought a lawsuit against Mississippi for its restrictions on the drug.

It’s possible for the DOJ to get involved in that case, but the government will have to contend with a number of challenges it wouldn’t have to deal with if it brought a lawsuit on its own, explained Cohen, the Harvard law vice dean.

First, the government will have to argue the case in whichever court the drug maker chooses.

“The [government] not getting to choose the venue is a bad thing,” he explained. “As the federal government, when you have the choice of venue that is a powerful thing.”

Second, the government will have to navigate the arguments already made by the drug maker.

“One thing about having a private party in the litigation is you can’t control exactly what their litigation position is,” he added.

And third, it also remains to be seen how much of an impact the government can have, given the case is relatively far along. GenBioPro first filed its lawsuit in Oct. 2020.

“I think they much rather would have been involved earlier,” Cohen said.

https://www.statnews.com/2022/06/24/the-biden-administration-wants-to-get-tough-on-states-abortion-pill-restrictions-it-wont-be-easy/

NY to roll out welcome mat for abortion tourism

 New York is gearing up for abortion tourism as officials and activists prepare to welcome women from out-of-state in the wake of the Supreme Court’s decision Friday to eliminate the constitutional right to an abortion.

“Abortion rights are enshrined in law in NY — including those coming from out of state,” tweeted Manhattan Borough President Mark Levine Saturday. “There are expanding options for accessing abortion services here, including via medication.”

Levine included information on several services for those seeking abortions from out-of-state, including links to websites of non-profits such as the Brigid Alliance, a referral service that provides lodging, food and financing for abortion seekers from outside New York.

Planned Parenthood of Greater New York, which operates 23 centers throughout the state, said it was increasing the availability of appointments by 20 percent in the wake of the decision on Roe v. Wade on Friday.

“Banning abortion does not take away people’s need to access abortion. We believe all people — no matter where they live — should have the right to control their own bodies, lives, and futures,” Joy Calloway, interim president and CEO of Planned Parenthood of Greater New York, said in a statement. “It is unacceptable that people in some states have been robbed of that right, forced to overcome unjust barriers to access the abortion care they need and deserve.” Planned Parenthood

Planned Parenthood of New York said they’re increasing appointments by 20 percent in response to the Supreme Court ruling.
LightRocket via Getty Images

But conservative critics were quick to slam the prospect of the city and state become the abortion capital of the United States.

“I think it’s a little grotesque that the city and state is turning into a hub for abortion,” said Gavin Wax, the president of the New York Young Republican Club. “I don’t think we should be encouraging abortion as if it’s a societal good. There are bigger questions here.”

The New York State Right to Life’s director said the group is going to “redouble” their efforts “to care for children and their mothers.”

New York City Mayor Eric Adams
New York City Mayor Eric Adams said that out-of-state women seeking abortions are welcome in New York City.
William Farrington
New York Attorney General Letitia James
New York Attorney General Letitia James promised to set aside $50 million for abortion seekers.
AFP via Getty Images

“The Supreme Court has made it possible for states to protect unborn children and their mothers,” said Anne LeBlanc, chair of New York State Right to Life in a statement to The Post. “It’s sad that New York instead seeks to further victimize them.”

Elected officials had been planning for the eventuality that the Supreme Court would overturn Roe v. Wade, and last month announced a host of funding and new measures to welcome out-of-state abortion seekers.

State Attorney General Letitia James promised last month to set aside $50 million to help women seeking abortions. Part of those funds will be used for women arriving in New York from other states where the procedures are illegal. In 2019, 9 percent, or about 7,000, of the abortions performed in New York were from people from out of state, according to James’ office. She said that number could increase exponentially, to 32,000, in the aftermath of the Supreme Court’s decision.

New York Governor Kathy Hochul
New York Governor Kathy Hochul declared New York a “safe harbor” for women seeking abortions.
Matthew McDermott

Mayor Eric Adams welcomed women seeking abortions to New York City, where the city has budgeted $250,000 a year for abortions since 2019.

“To those seeking abortions around the country: Know that you are welcome here and that we will make every effort to ensure our reproductive services are available and readily accessible to you,” Adams said in a statement. “This city will continue to respect, protect, and fulfill the core tenets of our fundamental rights to bodily autonomy and quality, critical, health care for those seeking access to an abortion.” 

On Friday, after the decision was announced, Gov. Kathy Hochul declared the state “a safe harbor” for women seeking abortions. Hochul announced an advertising campaign and new additions to a website that would help women in New York and throughout the country obtain information about abortions.

“This is repulsive at every level,” Hochul said.

https://nypost.com/2022/06/25/new-york-preparing-welcome-out-of-state-abortion-seekers/